150 related articles for article (PubMed ID: 10927157)
21. MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats.
Fournier LS; Novikov V; Lucidi V; Fu Y; Miller T; Floyd E; Shames DM; Brasch RC
Radiology; 2007 Apr; 243(1):105-11. PubMed ID: 17329684
[TBL] [Abstract][Full Text] [Related]
22. MR imaging of tumor microcirculation: promise for the new millennium.
Taylor JS; Tofts PS; Port R; Evelhoch JL; Knopp M; Reddick WE; Runge VM; Mayr N
J Magn Reson Imaging; 1999 Dec; 10(6):903-7. PubMed ID: 10581502
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.
Cohen FM; Kuwatsuru R; Shames DM; Neuder M; Mann JS; Vexler V; Rosenau W; Brasch RC
Invest Radiol; 1994 Nov; 29(11):970-7. PubMed ID: 7890512
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.
Ceelen W; Smeets P; Backes W; Van Damme N; Boterberg T; Demetter P; Bouckenooghe I; De Visschere M; Peeters M; Pattyn P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1188-96. PubMed ID: 16457965
[TBL] [Abstract][Full Text] [Related]
25. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging detects early changes in microvascular permeability in xenograft tumors after treatment with the matrix metalloprotease inhibitor Prinomastat.
Wiart M; Fournier LS; Novikov VY; Shames DM; Roberts TP; Fu Y; Shalinsky DR; Brasch RC
Technol Cancer Res Treat; 2004 Aug; 3(4):377-82. PubMed ID: 15270589
[TBL] [Abstract][Full Text] [Related]
27. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.
Jain R
NMR Biomed; 2013 Aug; 26(8):1042-9. PubMed ID: 23832526
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.
Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Zuna I; Knof A; Brix G; Schaeffer U; Wilkens C; Schoenberg SO; Essig M; Vaupel P; van Kaick G
Cancer Res; 1997 Nov; 57(21):4777-86. PubMed ID: 9354439
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.
Pham CD; Roberts TP; van Bruggen N; Melnyk O; Mann J; Ferrara N; Cohen RL; Brasch RC
Cancer Invest; 1998; 16(4):225-30. PubMed ID: 9589031
[TBL] [Abstract][Full Text] [Related]
30. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution.
Demsar F; Roberts TP; Schwickert HC; Shames DM; van Dijke CF; Mann JS; Saeed M; Brasch RC
Magn Reson Med; 1997 Feb; 37(2):236-42. PubMed ID: 9001148
[TBL] [Abstract][Full Text] [Related]
31. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
Daldrup H; Shames DM; Wendland M; Okuhata Y; Link TM; Rosenau W; Lu Y; Brasch RC
AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973
[TBL] [Abstract][Full Text] [Related]
32. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.
Cuenod CA; Fournier L; Balvay D; Guinebretière JM
Abdom Imaging; 2006; 31(2):188-93. PubMed ID: 16447089
[TBL] [Abstract][Full Text] [Related]
33. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
[TBL] [Abstract][Full Text] [Related]
34. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
[TBL] [Abstract][Full Text] [Related]
35. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
Hawighorst H; Knapstein PG; Knopp MV; Weikel W; Brix G; Zuna I; Schönberg SO; Essig M; Vaupel P; van Kaick G
Cancer Res; 1998 Aug; 58(16):3598-602. PubMed ID: 9721867
[TBL] [Abstract][Full Text] [Related]
36. [CT and MRI imaging in tumoral angiogenesis].
de Bazelaire C; Calmon R; Chapellier M; Pluvinage A; Frija J; de Kerviler E
Bull Cancer; 2010 Jan; 97(1):79-90. PubMed ID: 19858045
[TBL] [Abstract][Full Text] [Related]
37. [Effects of MRI-assayed microvascular permeability on the accumulation of vinorelbine in xenograft tumors].
Raatschen HJ; Fu Y; Rogut V; Simon GH; Sennino B; Wolf KJ; Brasch RC
Rofo; 2010 Feb; 182(2):133-9. PubMed ID: 19862658
[TBL] [Abstract][Full Text] [Related]
38. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.
Bhujwalla ZM; Artemov D; Natarajan K; Ackerstaff E; Solaiyappan M
Neoplasia; 2001; 3(2):143-53. PubMed ID: 11420750
[TBL] [Abstract][Full Text] [Related]
39. MRI of tumor angiogenesis.
Barrett T; Brechbiel M; Bernardo M; Choyke PL
J Magn Reson Imaging; 2007 Aug; 26(2):235-49. PubMed ID: 17623889
[TBL] [Abstract][Full Text] [Related]
40. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
Malamas AS; Jin E; Zhang Q; Haaga J; Lu ZR
Pharm Res; 2015 Sep; 32(9):3029-43. PubMed ID: 25840948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
